Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Non-Current Assets (2020 - 2026)

Alvotech's (ALVO) quarterly Non-Current Assets came in at $1.0 billion in Q2 2026, up 18.02% on a YoY basis from $883.3 million in Q2 2025, and up 8.01% quarter-over-quarter from $965.2 million in Q1 2026.

Analysis

Alvotech (ALVO) Non-Current Assets (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Non-Current Assets for 7 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets rose 18.02% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $3.9 billion (up 19.72% YoY), and the FY2025 full-year result was $913.1 million, up 19.14% from the prior year.
  • Non-Current Assets rose to $1.0 billion in Q2 2026 per ALVO's latest filing, from $965.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.0 billion in Q2 2026 and bottomed at $535.8 million in Q2 2022.
  • Historically, Non-Current Assets has averaged $803.6 million across 5 years, with a median of $784.9 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Assets jumped 30.4% in 2023, then gained 1.47% in 2024.
  • Over 5 years, Non-Current Assets stood at $597.7 million in 2022, then climbed by 26.36% to $755.2 million in 2023, then grew by 1.47% to $766.4 million in 2024, then advanced by 19.14% to $913.1 million in 2025, then advanced by 14.17% to $1.0 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $1.0 billion, $965.2 million, and $913.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 26.10 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 24.99 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 2.92 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 1.83 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 18.27 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 668.68 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 1.04 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 1.11 Bn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 3.25 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 2.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.04 Bn
Mar 31, 2026 965.19 Mn
Dec 31, 2025 913.08 Mn
Sep 30, 2025 954.16 Mn
Jun 30, 2025 883.29 Mn
Mar 31, 2025 786.59 Mn
Dec 31, 2024 766.38 Mn
Sep 30, 2024 800.34 Mn
Jun 30, 2024 783.29 Mn
Mar 31, 2024 768.34 Mn
Dec 31, 2023 755.25 Mn
Jun 30, 2023 698.75 Mn
Dec 31, 2022 597.71 Mn
Jun 30, 2022 535.84 Mn
Dec 31, 2021 478.16 Mn
Dec 31, 2020 388.26 Mn